ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

INMB INmune Bio Inc

11.63
0.00 (0.00%)
Pre Market
Last Updated: 04:00:01
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
INmune Bio Inc INMB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 11.63 04:00:01
Open Price Low Price High Price Close Price Prev Close
11.63
more quote information »

Recent News

Date Time Source Heading
3/27/202410:52IHNWFeaturedPOET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks
3/26/202416:01GLOBEINmune Bio Inc. to Report Fourth Quarter 2023 Financial..
3/13/202408:00GLOBEINmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives..
3/05/202408:00GLOBEINmune Bio Reports Significant EEG Improvement in..
2/12/202409:00GLOBEINmune Bio to Participate in the Oppenheimer 34th Annual..
2/06/202409:00GLOBEINmune Bio to Participate in Baird’s Biotech Discovery..
1/30/202408:02EDGAR2Form 8-K - Current report
1/30/202408:00GLOBEINmune Bio Announces FDA Removal of Clinical Hold for..
1/16/202408:30GLOBEELEVAI Labs, Inc. Acquires Worldwide License Agreement for..
1/02/202416:00EDGAR2Form 8-K - Current report
1/02/202408:00GLOBEINmune Bio Announces First Patient Dosed in a Phase 1/2..
12/18/202316:15EDGAR2Form 8-K - Current report
12/18/202316:05EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
12/18/202316:01EDGAR2Form 8-K - Current report
12/18/202316:01GLOBEINmune Bio Provides Update Regarding Global Alzheimer’s..
11/29/202316:00EDGAR2Form 8-K - Current report
11/29/202308:00GLOBEINmune Bio Inc. Demonstrates that INB03 Enhances the Uptake..
11/27/202316:00EDGAR2Form 8-K - Current report
11/27/202308:00GLOBEINmune Bio Receives EMA’s Authorization in France and Spain..
11/15/202316:13EDGAR2Form 8-K - Current report
11/15/202309:00GLOBEINmune Bio Inc. Announces Expansion of Phase II Clinical..
11/13/202311:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202316:13EDGAR2Form 8-K - Current report
11/01/202316:10GLOBEINmune Bio Inc. Announces Third Quarter 2023 Results and..
11/01/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/31/202316:25EDGAR2Form 8-K - Current report
10/31/202308:00GLOBEINmune Bio Inc. Patent Claims Covering INB16 Cell Line and..
10/30/202309:07GLOBEINmune Bio Inc. Presents Preclinical Data at SITC 2023..
10/17/202308:00GLOBEINmune Bio Inc. Presents New Biomarker and Feasibility Data..
10/16/202309:00GLOBEINmune Bio Inc. to Report Third Quarter 2023 Financial..
9/07/202309:10EDGAR2Form 8-K - Current report
9/07/202309:00GLOBEINmune Bio Inc. to Present at Baird Global Healthcare..
9/05/202316:00EDGAR2Form 8-K - Current report
9/05/202308:00GLOBEINmune Bio Inc. Announces Approval of Clinical Trial..
8/16/202316:41EDGAR2Form 8-K - Current report
8/16/202316:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/08/202316:01EDGAR2Form 8-K - Current report
8/07/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202316:00GLOBEINmune Bio Inc. Announces Second Quarter 2023 Results and..
8/02/202306:02EDGAR2Form 8-K - Current report
8/01/202308:00GLOBEINmune Bio Inc. to Present at the BTIG Virtual ..
7/31/202308:00GLOBEINmune Bio, Inc. to Report Second Quarter 2023 Financial..
7/27/202316:43EDGAR2Form 8-K - Current report
7/14/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/12/202316:00EDGAR2Form 8-K - Current report
7/12/202313:23EDGAR2Form 144 - Report of proposed sale of securities
7/12/202308:00GLOBEINmune Bio Inc. to Deliver Keynote Talk at 5th World Aging..
7/11/202308:00GLOBEINmune Bio Inc. Announces Novel MRI Biomarker Data..
7/10/202316:00GLOBEINmune Bio Inc. Announces Data Presented at the 16th..
5/24/202309:00GLOBEINmune Bio Inc.’s Chief Scientific Officer, Mark Lowdell,..
5/08/202308:00GLOBEINmune Bio, Inc. Announces FDA Clearance of IND Application..

Your Recent History

Delayed Upgrade Clock